Impact of Thoracic Recurrent Laryngeal Node Dissection: 508 Patients with Tri-Incisional Esophagectomy
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
To evaluate the feasibility and safety of recurrent laryngeal nerve (RLN) lymph node (LN) dissection, this study compared the postoperative complications and survival between modern two-field lymphadenectomy (MTL) and modified standard two-field lymphadenectomy (MSTL) by using the propensity score matching method.
After generating propensity scores given the covariates of age, sex, tumor length, tumor location, tumor grade, and clinical stage, 254 patients with MTL were matched to 254 MSTL patients using the nearest available score matching. The LNs resected during MSTL were paraesophageal and preparatracheal LNs in the upper mediastinum, in addition to those resected during standard two-field lymphadenectomy.
RLN LNs were those most commonly affected by nodal metastasis in our series (26 %). Metastasis in RLN LNs was found in around 35, 25, and 20 % of patients with cancer in the upper, middle, and lower thoracic esophagus, respectively. LN metastasis was confined to the RLN region in 49 patients. Even 35 % of patients with pT1 tumors had positive RLN LNs. MTL increased the mean number of resected LNs when compared to MSTL (29 vs.15; p < 0.001). Recurrence was more frequent in those assigned MSTL than those assigned MTL (p < 0.001). The 5-year overall survival (OS) and disease-free survival (DFS) rate for MTL were 50.7 and 42 % compared to 35.3 and 28.2 % for MSTL (both p < 0.001), respectively. Postoperative complications were more frequent following MTL when compared to the MSTL. However, no statistically significant difference in postoperative complications was observed between the two groups.
Adding the removal of RLN LNs might improve OS and DFS with acceptable morbidity for patients with ESCC.
- Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011; 61(2): 69–90. CrossRef
- Jamieson GG, Lamb PJ, Thompson SK, et al. The role of lymphadenectomy in esophageal cancer. Ann Surg, 2009; 250(2): 206–9. CrossRef
- Akiyama H, Tsurumaru, M, Udagawa, H, Kajiyama, Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg, 1994; 220(3): 364–72. CrossRef
- Lerut T, Nafteux P, Moons J, et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg, 2004; 240(6): 962–72. CrossRef
- Nozoe T, Kakeji Y, Baba H, Maehara, Y. Two-field lymph-node dissection may be enough to treat patients with submucosal squamous cell carcinoma of the thoracic esophagus. Dis Esophagus, 2005; 18(4): 226–9. CrossRef
- Fujita H, Kakegawa T, Yamana H, et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg, 1995; 222(5): 654–62. CrossRef
- Fujita H, Kakegawa T, Yamana H, et al. Lymph node metastasis and recurrence in patients with a carcinoma of the thoracic esophagus who underwent three-field dissection. World J Surg, 1994; 18(2): 266–72. CrossRef
- Shiozaki H, Yano M, Tsujinaka T, et al. Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer. Dis Esophagus, 2001; 14(3–4): 191–6. CrossRef
- Tabira Y, Yasunaga M, Tanaka M, et al. Recurrent nerve nodal involvement is associated with cervical nodal metastasis in thoracic esophageal carcinoma. J Am Coll Surg, 2000; 191(3): 232–7. CrossRef
- D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265–81 CrossRef
- Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 1985; 39: 33–38.
- Edge SB, Byrd DR, Compton CC , et al. American Joint Committee on Cancer (AJCC) cancer staging manual, 7th ed. Chicago: Springer, Inc; 2010.
- Akiyama H, et al. Surgery for Cancer of the Esophagus. Baltimore: Williams & Wilkins, 1990: 19–42.
- Bumm R, Wong J. More or less surgery for esophageal cancer: extent of lymphadenectomy for squamous cell esophageal carcinoma-How much is necessary? Dis Esophagus. 1994; 7 (3):151–55
- Shiraha S. Experimental studies on the lymphatics of the esophagus from the surgical point of view. Nihon Geka Hokan, 1969; 38(4): 543–64.
- Kuge K, Murakami G, Mizobuchi S, Hata, Y, Aikou, T, Sasaguri, S. Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus. J Thorac Cardiovasc Surg, 2003; 125(6): 1343–9. CrossRef
- Fujita H, Sueyoshi S, Tanaka T,Shirouzu K. Three-field dissection for squamous cell carcinoma in the thoracic esophagus. Ann Thorac Cardiovasc Surg, 2002; 8(6): 328–35.
- Altorki NK, Zhou, X K, Stiles, B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg, 2008; 248(2): 221–6. CrossRef
- Stiles BM, Nasar Abu, Mirza FA, et al. Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy. European Journal of Cardio-Thoracic Surgery, 2012; 42 (4):659–64. CrossRef
- Isono K, Onoda S, Okuyama, K, Sato, H. Recurrence of intrathoracic esophageal cancer. Jpn J Clin Oncol, 1985; 15(1):49–60.
- Malassagne B, et al. Prognostic value of thoracic recurrent nerve nodal involvement in esophageal squamous cell carcinoma. J Am Coll Surg, 1997; 185(3): 244–9.
- Impact of Thoracic Recurrent Laryngeal Node Dissection: 508 Patients with Tri-Incisional Esophagectomy
Journal of Gastrointestinal Surgery
Volume 18, Issue 1 , pp 187-193
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Esophageal cancer
- Lymph nodes
- Industry Sectors
- Author Affiliations
- 1. Gastrointestinal Institute of Sun Yat-sen University, Department of Thoracic Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
- 2. State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China
- 3. Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China